MRK

Merck News

Company Name Stock Ticker Symbol Market Type
Merck and Co Inc MRK NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
1.32 1.24% 107.41 18:36:52
Open Price Low Price High Price Close Price Prev Close
106.10 105.90 107.44 107.41 106.09
more quote information »

Recent News

Date Time Source Heading
1/27/202306:45BWFDA Approves KEYTRUDA® (pembrolizumab) as Adjuvant Treatment..
1/26/202308:02BWMerck Animal Health Receives U.S. FDA Approval of Expanded..
1/25/202317:35EDGARStatement of Changes in Beneficial Ownership (4)
1/25/202317:27EDGARStatement of Changes in Beneficial Ownership (4)
1/25/202317:04EDGARStatement of Changes in Beneficial Ownership (4)
1/25/202316:53EDGARStatement of Changes in Beneficial Ownership (4)
1/25/202316:42EDGARStatement of Changes in Beneficial Ownership (4)
1/25/202307:44DJNMerck Reports Keytruda Phase 3 Success, Failure
1/25/202306:50BWMerck Announces KEYNOTE-991 Trial Evaluating KEYTRUDA®..
1/25/202306:45BWMerck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy..
1/24/202313:19BWMerck Announces Second-Quarter 2023 Dividend
1/17/202322:58PRNCAMerck Selects Perceiv AI for Inaugural Digital Sciences..
1/11/202316:23EDGARStatement of Changes in Beneficial Ownership (4)
1/11/202306:45BWMerck Completes Tender Offer to Acquire Imago BioSciences,..
1/10/202309:00BWMerck Named One of America’s Most JUST Companies by JUST..
1/05/202306:45BWMerck to Hold Fourth-Quarter and Full-Year 2022 Sales and..
1/03/202316:42EDGARStatement of Changes in Beneficial Ownership (4)
1/03/202316:36EDGARStatement of Changes in Beneficial Ownership (4)
1/03/202316:30EDGARStatement of Changes in Beneficial Ownership (4)
1/03/202306:45BWMerck to Present at the 41st Annual J.P. Morgan Healthcare..
12/30/202213:39DJNTrending: Merck's Molnupiravir Approved for Emergency Use in..
12/30/202207:33DJNChina Approves Merck's Molnupiravir for Emergency Use,..
12/30/202204:07DJNCorrection to Molnupiravir Approved in China Article
12/30/202203:39DJNChina Approves Merck's Molnupiravir for Emergency Use,..
12/22/202207:00BWMerck to Present at the Goldman Sachs Healthcare CEOs..
12/22/202206:45BWMerck and Kelun-Biotech Announce Exclusive License and..
12/21/202206:45BWLYNPARZA® (olaparib) in Combination With Abiraterone and..
12/20/202206:45BWSeagen, Astellas and Merck Announce FDA Acceptance of sBLAs..
12/15/202207:30DJNMerck, AstraZeneca Receive FDA Extension on Lynparza New..
12/15/202206:45BWAstraZeneca and Merck Provide Update on US Regulatory Review..
12/13/202214:33DJNTrending: Moderna, Merck Say Cancer Vaccine and Keytruda..
12/12/202206:45BWMerck Begins Tender Offer to Acquire Imago BioSciences, Inc.
12/09/202200:55TRMNSVB Securities Keeps Their Buy Rating on Merck & Company..
12/01/202206:45BWMerck to Present Data From Its Hematology Portfolio and..
11/29/202211:41BWMerck Announces First-Quarter 2023 Dividend
11/23/202202:44DJNMerck's Keytruda Hits Main Endpoint in Stomach Cancer Study
11/22/202222:35TRMNMerck & Company (MRK) Gets a Buy from SVB Securities
11/22/202206:45BWMerck Announces Phase 3 KEYNOTE-859 Trial Met Primary..
11/21/202214:35DJNTrending: Merck to Acquire Imago BioSciences for $1.35..
11/21/202210:32DJNImago BioSciences Shares Take Flight on Takeover by Merck
11/21/202208:55TRMNMizuho Securities Reaffirms Their Buy Rating on Merck &..
11/21/202207:29DJNMerck to Buy Imago for $36 A Share, More Than Double..
11/21/202206:45BWMerck to Present at the 5th Annual Evercore ISI HealthCONx..
11/14/202206:45BWLYNPARZA® (olaparib) in Combination With Abiraterone and..
11/10/202217:03EDGARStatement of Changes in Beneficial Ownership (4)
11/10/202216:47EDGARStatement of Changes in Beneficial Ownership (4)
11/10/202216:45EDGARStatement of Changes in Beneficial Ownership (4)
11/08/202216:58EDGARStatement of Changes in Beneficial Ownership (4)
11/07/202216:10EDGARStatement of Changes in Beneficial Ownership (4)
11/07/202216:08EDGARStatement of Changes in Beneficial Ownership (4)
Your Recent History
NYSE
MRK
Merck
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230131 23:56:56